# AbbVie, Inc.

- Location (FDA's records): North Chicago, IL
- FDA decisions: 7 (2014–2026): 7 510(k) clearances
- Names in FDA's records: AbbVie , Inc. (6); AbbVie (1)
- Product codes: KNT (6), LCJ (1)
- Predicates its devices cite: 7 (3 its own); citations of its devices by later devices: 3 (3 its own)
- Recalls linked to its devices: 4 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Boston Scientific Corp: 2 (https://510kreport.com/company/boston-scientific)
- Biosearch Medical Products, Inc.: 1 (https://510kreport.com/company/biosearch-medical-products)
- Allergan, Inc.: 1 (https://510kreport.com/company/allergan)

## Its most-cited devices
- K133129: Abbvie NJ (2014), cited by 1
- K133096: Abb Vie J (2014), cited by 1
- K133087: Abbvie Peg (2014), cited by 1

## Recent decisions
- K254126: Natrelle 133S Tissue Expanders (Jan 16, 2026)
- K142792: AbbVie NJ (Jan 14, 2015)
- K142816: AbbVie J (Jan 14, 2015)
- K142793: AbbVie PEG (Jan 14, 2015)
- K133129: Abbvie NJ (Jun 19, 2014)
- K133087: Abbvie Peg (Jun 19, 2014)
- K133096: Abb Vie J (Jun 18, 2014)

Source page: https://510kreport.com/company/abbvie